Radford-Smith G - Search Results

1

HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.

Heap GA, Weedon MN, Bewshea CM, Singh A, Chen M, Satchwell JB, Vivian JP, So K, Dubois PC, Andrews JM, Annese V, Bampton P, Barnardo M, Bell S, Cole A, Connor SJ, Creed T, Cummings FR, D'Amato M, Daneshmend TK, Fedorak RN, Florin TH, Gaya DR, Greig E, Halfvarson J, Hart A, Irving PM, Jones G, Karban A, Lawrance IC, Lee JC, Lees C, Lev-Tzion R, Lindsay JO, Mansfield J, Mawdsley J, Mazhar Z, Parkes M, Parnell K, Orchard TR, Radford-Smith G, Russell RK, Reffitt D, Satsangi J, Silverberg MS, Sturniolo GC, Tremelling M, Tsianos EV, van Heel DA, Walsh A, Watermeyer G, Weersma RK, Zeissig S, Rossjohn J, Holden AL; International Serious Adverse Events Consortium; IBD Pharmacogenetics Study Group; Ahmad T. Heap GA, et al. Nat Genet. 2014 Oct;46(10):1131-4. doi: 10.1038/ng.3093. Epub 2014 Sep 14. Nat Genet. 2014. PMID: 25217962 Free PMC article.

2

The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction.

Pierik M, Yang H, Barmada MM, Cavanaugh JA, Annese V, Brant SR, Cho JH, Duerr RH, Hugot JP, McGovern DP, Paavola-Sakki P, Radford-Smith GL, Pavli P, Silverberg MS, Schreiber S, Taylor KD, Vlietinck R; IBD International Genetics Consortium. Pierik M, et al. Inflamm Bowel Dis. 2005 Jan;11(1):1-7. doi: 10.1097/00054725-200501000-00001. Inflamm Bowel Dis. 2005. PMID: 15674107

3

Clinically active Crohn's disease in the presence of a low C-reactive protein.

Florin TH, Paterson EW, Fowler EV, Radford-Smith GL. Florin TH, et al. Scand J Gastroenterol. 2006 Mar;41(3):306-11. doi: 10.1080/00365520500217118. Scand J Gastroenterol. 2006. PMID: 16497618

4

Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease.

Gibson PR, Weston AR, Shann A, Florin TH, Lawrance IC, Macrae FA, Radford-Smith G. Gibson PR, et al. J Gastroenterol Hepatol. 2007 Aug;22(8):1306-12. doi: 10.1111/j.1440-1746.2007.04930.x. Epub 2007 Jun 7. J Gastroenterol Hepatol. 2007. PMID: 17559375

5

Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population.

Hume GE, Fowler EV, Doecke J, Simms LA, Huang N, Palmieri O, Griffiths LR, Florin TH, Annese V, Radford-Smith GL. Hume GE, et al. Inflamm Bowel Dis. 2008 May;14(5):585-90. doi: 10.1002/ibd.20362. Inflamm Bowel Dis. 2008. PMID: 18213697

6

Intestinal barrier dysfunction in inflammatory bowel diseases.

McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. McGuckin MA, et al. Inflamm Bowel Dis. 2009 Jan;15(1):100-13. doi: 10.1002/ibd.20539. Inflamm Bowel Dis. 2009. PMID: 18623167 Free article. Review.

7

ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity.

Fowler EV, Doecke J, Simms LA, Zhao ZZ, Webb PM, Hayward NK, Whiteman DC, Florin TH, Montgomery GW, Cavanaugh JA, Radford-Smith GL. Fowler EV, et al. Am J Gastroenterol. 2008 Oct;103(10):2519-26. doi: 10.1111/j.1572-0241.2008.02023.x. Epub 2008 Jul 30. Am J Gastroenterol. 2008. PMID: 18671817

8

Anti-tumour necrosis factor-alpha treatment for perianal Crohn's disease in Australia.

Burger DC, Lawrance IC, Bampton PA, Prosser R, Croft A, Gilshenan K, Radford-Smith GL, Florin TH. Burger DC, et al. Med J Aust. 2010 Apr 5;192(7):375-7. doi: 10.5694/j.1326-5377.2010.tb03557.x. Med J Aust. 2010. PMID: 20367582

9

KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population.

Simms LA, Doecke JD, Roberts RL, Fowler EV, Zhao ZZ, McGuckin MA, Huang N, Hayward NK, Webb PM, Whiteman DC, Cavanaugh JA, McCallum R, Florin TH, Barclay ML, Gearry RB, Merriman TR, Montgomery GW, Radford-Smith GL. Simms LA, et al. Am J Gastroenterol. 2010 Oct;105(10):2209-17. doi: 10.1038/ajg.2010.161. Epub 2010 Apr 20. Am J Gastroenterol. 2010. PMID: 20407432

10

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.

Lawrance IC, Radford-Smith GL, Bampton PA, Andrews JM, Tan PK, Croft A, Gearry RB, Florin TH. Lawrance IC, et al. J Gastroenterol Hepatol. 2010 Nov;25(11):1732-8. doi: 10.1111/j.1440-1746.2010.06407.x. J Gastroenterol Hepatol. 2010. PMID: 21039834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page